Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer

Blood. 2007 Aug 15;110(4):1330-3. doi: 10.1182/blood-2007-03-081133. Epub 2007 May 11.

Abstract

Signal transducer and activator of transcription 3 (Stat3) is implicated in the pathogenesis of many malignancies and essential for IL-6-dependent survival and growth of multiple myeloma cells. Here, we demonstrate that the gene encoding oncogenic microRNA-21 (miR-21) is controlled by an upstream enhancer containing 2 Stat3 binding sites strictly conserved since the first observed evolutionary appearance of miR-21 and Stat3. MiR-21 induction by IL-6 was strictly Stat3 dependent. Ectopically raising miR-21 expression in myeloma cells in the absence of IL-6 significantly reduced their apoptosis levels. These data provide strong evidence that miR-21 induction contributes to the oncogenic potential of Stat3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Cell Line, Tumor
  • Chromatin Immunoprecipitation
  • Enhancer Elements, Genetic / genetics*
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Interleukin-6 / pharmacology*
  • MicroRNAs / physiology*
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / genetics*
  • Multiple Myeloma / metabolism*
  • STAT3 Transcription Factor / metabolism*
  • Transcription, Genetic

Substances

  • Interleukin-6
  • MicroRNAs
  • STAT3 Transcription Factor
  • STAT3 protein, human